Every Form 4 that Stereotaxis, Inc. (STXS) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow STXS and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full STXS filings page.
SHAMIR NACHUM reported acquisition or exercise transactions in this Form 4 filing.
Stereotaxis, Inc. director Shamir Nachum reported an equity compensation grant in the form of restricted share units tied to the company’s common stock. The award covers 43,103 restricted share units, each representing one future share, granted at a stated price of $0.00 per share as typical for compensation grants.
Following this award, Nachum’s direct holdings increased to 179,327 shares of common stock. The restricted share units vest on the earliest of three events: the fifth anniversary of the award date, the director’s departure from the board, or a defined Change of Control, aligning vesting with long-term service or a major corporate event.
Benfer David reported acquisition or exercise transactions in this Form 4 filing.
Stereotaxis, Inc. director David Benfer reported an equity compensation grant, not an open-market trade. He received 43,103 restricted share units, each convertible into one share of common stock, at a price of $0.00 per share. The footnote states these restricted share units vest immediately on the grant date, so they effectively become common shares right away.
Following the grant, Benfer directly holds 558,975 shares of Stereotaxis common stock. He also has indirect ownership interests, including 210,255 shares held by the Benfer Family Trust and 2,700 shares held by his spouse as of the same date.
Levin Ross B reported acquisition or exercise transactions in this Form 4 filing.
Stereotaxis, Inc. director Ross B. Levin reported a grant of 43,103 restricted share units, each representing one share of common stock. These units vest on the earliest of the fifth anniversary of the award date, the end of his board service, or a defined Change of Control. Following this award, Levin directly holds 621,248 shares of common stock.
Curet Myriam reported acquisition or exercise transactions in this Form 4 filing.
Stereotaxis, Inc. director Myriam Curet reported receiving an equity award of 43,103 restricted share units, each representing one share of common stock. The grant was made at no cash cost to her and increased her directly owned stake to 435,161 shares.
The restricted share units vest on the earliest of the fifth anniversary of the award date, the end of her board service, or a defined Change of Control event, aligning her compensation with the company’s long-term performance and governance outcomes.
Fischel Nathan reported acquisition or exercise transactions in this Form 4 filing.
Stereotaxis, Inc. director and ten percent owner Nathan Fischel reported a grant of 43,103 restricted share units of common stock. The award has a grant price of $0.00 per unit, reflecting a compensation-related equity grant rather than an open-market purchase.
These restricted share units vest on the earliest of the fifth anniversary of the award date, the end of his board service, or a defined Change of Control. Following this grant, Fischel holds 720,775 shares of common stock directly. A separate line shows 13,680,554 shares held indirectly by funds managed by DAFNA Capital Management LLC, where he serves as Chief Executive Officer.
Menawat Arun Swarup reported acquisition or exercise transactions in this Form 4 filing.
Stereotaxis, Inc. director Arun Swarup Menawat received an equity grant of 43,103 shares of Common Stock as a compensation award. The shares were granted at no cash cost to him and increased his direct holdings to 1,035,560 shares following the transaction.
The award is structured as restricted share units, each convertible into one share of common stock. These units vest on the earliest of the fifth anniversary of the award date, the end of his board service, or a defined Change of Control, which ties the compensation to long-term service and corporate outcomes.
Stereotaxis, Inc. Chief Financial Officer Kimberly R. Peery received a grant of stock options for 40,000 shares of common stock. The options carry an exercise price of $1.87 per share and expire on April 11, 2036, functioning as compensation rather than an open‑market purchase.
According to the vesting terms, 25% of the options vest one year after the grant date, with the remaining 75% vesting monthly over the next three years. Following this grant, Peery directly holds 340,750 derivative securities in total.
Stereotaxis, Inc. director Arun S. Menawat reported receiving a new equity award in the form of restricted share units of the company’s common stock. On 01/02/2026, he was granted 46,948 shares of common stock at a stated price of $0, increasing his directly held beneficial ownership to 992,457 shares after the transaction.
The filing explains that each restricted share unit represents the right to receive one share of common stock. These units vest on the earliest of three events: the fifth anniversary of the award date, the date his service as a director on the board ends, or the occurrence of a Change of Control as defined in the award documents.
Stereotaxis, Inc. director David Benfer reported an equity award of 46,948 shares of common stock on 01/02/2026. These were granted as restricted share units, each representing the right to receive one share of common stock at a price of $0 per share.
The restricted share units vest on the earliest of the fifth anniversary of the award date, the date his board service ends, or a Change of Control as defined in the award documents. After this grant, Benfer beneficially owns 515,872 shares directly, 2,700 shares indirectly through his spouse, and 210,255 shares indirectly through the Benfer Family Trust.
Stereotaxis, Inc. reported an equity award to one of its directors. On 01/02/2026, the director received a grant of 46,948 restricted share units, each representing a right to receive one share of Stereotaxis common stock. The transaction price is listed as $0, reflecting that this was an equity compensation grant rather than a market purchase.
After this award, the director beneficially owns 392,058 shares of common stock. The restricted share units vest on the earliest of the fifth anniversary of the award date, the date the director’s board service ends, or a defined Change of Control event. This filing is a routine disclosure of director compensation and ownership under insider reporting rules.
Stereotaxis, Inc. insider Nathan Fischel reported a new equity award. On 01/02/2026, he received 46,948 restricted share units of Stereotaxis common stock at a price of $0. Each unit represents one share of common stock.
The restricted share units vest on the earliest of the fifth anniversary of the award date, the end of his service on the board of directors, or a defined Change of Control. Following this grant, Fischel beneficially owns 677,672 shares directly.
He also has indirect beneficial ownership of 13,680,554 shares held by funds for which DAFNA Capital Management LLC serves as investment manager and general partner. Fischel is the Chief Executive Officer of DAFNA Capital Management LLC and is identified as both a director and a 10% owner of Stereotaxis.
Stereotaxis, Inc. reported an equity award to a company director. On 01/02/2026, the director received 46,948 shares of common stock as a grant of restricted share units at a stated price of $0 per share. Following this grant, the director beneficially owned 578,145 shares of Stereotaxis common stock in direct ownership.
The filing explains that each restricted share unit represents the right to receive one share of common stock. These units vest on the earliest of three events: the fifth anniversary of the award date, the date the director’s board service ends, or a defined Change of Control under the award documents. The report is signed by an attorney-in-fact for director Ross B. Levin, indicating this is routine insider equity compensation rather than a market sale.
Stereotaxis, Inc. director reports equity grant
A director of Stereotaxis, Inc. (STXS) reported receiving 46,948 shares of common stock on 01/02/2026 in a transaction valued at $0 per share. After this grant, the director beneficially owns 136,224 shares of Stereotaxis common stock in direct ownership.
The grant consists of restricted share units, each representing the right to receive one share of common stock. These units vest on the earliest of the fifth anniversary of the award date, the date the director’s service on the board ends, or a Change of Control as defined in the award documents.
Stereotaxis, Inc. (STXS) insider Paul J. Isaac reported open-market purchases of the company’s common stock. On 11/14/2025, an indirect account bought 20,000 shares at $2.24 per share, bringing indirect beneficial ownership to 2,786,557 shares held through Arbiter Partners Capital Management LLC and related managed accounts. On 11/17/2025, a direct account purchased 10,000 shares at $2.18 per share, resulting in 97,299 shares held directly. The filing explains that Arbiter is a registered investment adviser, that Isaac’s reported holdings include shares owned by an affiliated fund and managed accounts, and that he disclaims beneficial ownership except to the extent of his pecuniary interest.
The remarks note that Ross B. Levin, Arbiter’s Director of Research, serves on Stereotaxis’s board of directors and that this Form 4 is filed as a matter of caution without conceding that Isaac, Arbiter or the fund are statutory insiders.